Clinical Trials on Malignant Solid Tumors in Japan
Total 434 results
-
Daiichi SankyoRecruitingAdvanced Solid TumorJapan, United States
-
Astellas Pharma Global Development, Inc.Active, not recruiting
-
Merck Sharp & Dohme LLCActive, not recruitingSolid TumorsPoland, Korea, Republic of, United States, Argentina, Australia, Canada, Colombia, France, Germany, Guatemala, Israel, Italy, Japan, Latvia, Mexico, Peru, Puerto Rico, Romania, South Africa, Spain, Sweden, Turkey, Ukraine
-
AbbVieActive, not recruitingAdvanced Solid Tumors CancerUnited States, Belgium, France, Italy, Japan, Korea, Republic of, Netherlands, Taiwan, Finland
-
AstraZenecaCompletedAdvanced Solid TumorsJapan, Korea, Republic of, Taiwan
-
Novartis PharmaceuticalsTerminatedSolid TumorsUnited States, Germany, Spain, Belgium, Korea, Republic of, Japan, Italy
-
Hoffmann-La RocheCompletedSolid TumorUnited States, Korea, Republic of, Taiwan, Australia, Japan, New Zealand, China
-
Novartis PharmaceuticalsCompletedAdvanced Solid and Hematological TP53wt TumorsFrance, Netherlands, Spain, Germany, Singapore, Japan, Taiwan, United States
-
TakedaTakeda Development Center Americas, Inc.Active, not recruitingAdvanced or Metastatic Solid TumorsUnited States, China, Croatia, Japan, Latvia, Poland, Brazil, Lithuania, Switzerland
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedBroad Solid TumorUnited States, Argentina, Australia, Canada, Chile, Japan, Romania, Singapore
-
Hoffmann-La RocheActive, not recruitingSolid TumorKorea, Republic of, China, France, Portugal, Spain, Brazil, Germany, Italy, Peru, Russian Federation, Japan, Ukraine, Costa Rica, Mexico, Poland
-
Kochi UniversityAvailableBoth Benign and Malignant Liver MassJapan
-
PfizerCompletedNeoplasm, MalignantJapan
-
SanofiCompletedNeoplasm MalignantJapan
-
AstraZenecaRecruitingAdvanced Solid Tumours That Are MTAP DeficientUnited States, Spain, Korea, Republic of, Australia, Japan, China, Netherlands, France
-
National Cancer Center, JapanEisai Co., Ltd.Active, not recruitingAdvanced or Recurrent Solid Tumors | FGFR Gene AlterationsJapan
-
Eli Lilly and CompanyActive, not recruitingSolid TumorUnited States, Spain, Japan, France, Italy, Australia, Germany, Canada
-
Calico Life Sciences LLCAbbVieRecruitingAdvanced Solid Tumors CancerKorea, Republic of, Taiwan, Spain, United States, France, Japan, Israel
-
Merck KGaA, Darmstadt, GermanyThreshold PharmaceuticalsCompletedPancreatic Cancer | Solid TumorJapan
-
AstraZenecaCompletedPart A and B: Advanced Solid Malignancies | Part C: Malignant MesotheliomaJapan
-
Eli Lilly and CompanyCompletedLymphoma | Carcinoma, Non-Small-Cell Lung | Solid TumorsJapan
-
AstraZenecaActive, not recruitingAdvanced Solid MalignanciesJapan
-
AstraZenecaCompleted
-
SanofiCompletedNeoplasm MalignantJapan
-
SanofiCompleted
-
Eisai Co., Ltd.Completed
-
Calico Life Sciences LLCAbbVieRecruitingAdvanced Solid Tumor CancerUnited States, Korea, Republic of, Spain, Israel, Japan, France
-
PfizerTerminatedLocally Advanced or Metastatic Solid Tumors | Genes, BRCA 1United States, Belgium, Spain, Denmark, Japan, France, Italy, Netherlands, United Kingdom
-
Merck Sharp & Dohme LLCActive, not recruitingAdvanced or Metastatic Solid TumorsChile, Hungary, Korea, Republic of, South Africa, Spain, Japan
-
Astellas Pharma IncRecruitingSolid TumorUnited States, Japan, France
-
AstraZenecaCompleted
-
Merck KGaA, Darmstadt, GermanyMerck Serono Co., Ltd., JapanTerminatedHepatocellular Carcinoma | Advanced Solid TumorsJapan
-
AstraZenecaCompletedAdvanced Solid MalignanciesJapan
-
AstraZenecaCompletedAdvanced Solid MalignanciesJapan
-
AmgenCompletedAdvanced Solid TumorsCanada, United States, Belgium, Spain, Brazil, Korea, Republic of, Poland, Singapore, Taiwan, Japan, United Kingdom, Australia, Turkey
-
Novartis PharmaceuticalsTerminatedAdvanced Solid TumorSpain, Singapore, Japan, United States, Canada
-
Merck Sharp & Dohme LLCCompletedAdvanced Solid TumorsUnited States, Australia, Canada, Chile, China, France, Greece, Israel, Italy, Japan, Korea, Republic of, New Zealand, Poland, South Africa, Spain, Sweden
-
GenmabSeagen Inc.Completed
-
AstraZenecaMedImmune LLCCompletedCancer | Advanced Solid MalignanciesJapan
-
AmgenActive, not recruitingKRAS p.G12C Mutant Advanced Solid TumorsUnited States, France, Canada, Spain, Belgium, Korea, Republic of, Austria, Australia, Hungary, Greece, Germany, Japan, Romania, Switzerland, Brazil, Portugal
-
Turning Point Therapeutics, Inc.Zai Lab (Shanghai) Co., Ltd.RecruitingLocally Advanced Solid Tumors | Metastatic Solid TumorsUnited States, China, Japan, Australia, Belgium, Canada, Denmark, France, Germany, Hong Kong, Hungary, Italy, Korea, Democratic People's Republic of, Korea, Republic of, Netherlands, Poland, Singapore, Spain, Taiwan, United Kingdom
-
Janssen Research & Development, LLCActive, not recruitingAdvanced Solid TumorFrance, United States, Japan, Belgium, United Kingdom, Germany, Taiwan, China, Korea, Republic of, Poland, Italy, Spain, Australia, Brazil, Argentina
-
AstraZenecaActive, not recruiting
-
Novartis PharmaceuticalsCompleted
-
Eli Lilly and CompanyParexel; Medidata SolutionsCompleted
-
Daiichi Sankyo Co., Ltd.RecruitingTenosynovial Giant Cell TumorJapan
-
AmgenRecruitingAdvanced Solid TumorsTaiwan, Australia, United States, Japan, Korea, Republic of, Poland
-
BayerBristol Myers Squibb Co. and Ono Pharmaceutical Co., LtdActive, not recruitingSolid TumorsUnited States, United Kingdom, Belgium, France, Taiwan, Japan, Italy, Korea, Republic of
-
AstraZenecaCompletedCarcinoma | Cancer | TumorsJapan
-
Puma Biotechnology, Inc.Completed